Evidence map›Paper›PMID 33693235›Full record

ArticleCirculation reports2020

Risk Profiling of Cancer Treatment-Related Cardiovascular Disorders in Breast Cancer Patients Who Received Adjuvant Chemotherapy With Trastuzumab.

Hiromi Shinano, Sakiko Miyazaki, Kayo Miura, Hiroshi Ohtsu, Naohiro Yonemoto, Kiyoshi Matsuoka, Hakuou Konishi, Hiroyuki Daida, Mitsue Saito, Kazuhiro Sase

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hiromi ShinanoClinical Pharmacology and Regulatory Science, Graduate School of Medicine, Juntendo University Tokyo Japan.
Sakiko MiyazakiDepartment of Cardiovascular Medicine, Graduate School of Medicine, Juntendo University Tokyo Japan.
Kayo MiuraDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Juntendo University Tokyo Japan.
Hiroshi OhtsuLeading Center for the Development and Research of Cancer Medicine, Juntendo University Tokyo Japan.
Naohiro YonemotoInnovative Medical Technology Research & Development Center, Juntendo University Tokyo Japan.
Kiyoshi MatsuokaInnovative Medical Technology Research & Development Center, Juntendo University Tokyo Japan.
Hakuou KonishiDepartment of Cardiovascular Medicine, Graduate School of Medicine, Juntendo University Tokyo Japan.
Hiroyuki DaidaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Juntendo University Tokyo Japan.
Mitsue SaitoDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Juntendo University Tokyo Japan.
Kazuhiro SaseClinical Pharmacology and Regulatory Science, Graduate School of Medicine, Juntendo University Tokyo Japan.
Juntendo University · JPNational Center for Global Health and Medicine · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast cancerCancer treatment-related cardiovascular disorderCardio-oncologyCardiovascular risk factorTrastuzumab

Identifiers

PMID33693235
PMCPMC7921354
OpenAlexW3013109058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.